Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Michael Borre1,2, John Brandt Brodersen3,4,5, Henrik Jacobsen6

  • 1Urinvejskirurgi, Aarhus Universitetshospital.

Ugeskrift for Laeger
|April 14, 2023
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prostate Cancer Screening: The Population Benefit Outweighs the Harm - Con.

European urology focus·2026
Same author

Corrigendum to "Robot-assisted Kidney Transplantation: The 8-year European experience" [Eur. Urol. 87(4) (2025) 468-475].

European urology·2026
Same author

Detection of prostate cancer by magnetic resonance imaging before biopsy - real-world evidence from a nationwide cohort study.

Scandinavian journal of urology·2026
Same author

Outcomes after kidney transplantation in patients with urinary diversions or bladder augmentations: A 20-year nationwide study.

Investigative and clinical urology·2026
Same author

IMPACT-Introduction of Mycotic Prophylaxis At Cystectomy Trial: perioperative mycotic prophylaxis with fluconazole to reduce postoperative complications following cystectomy-study protocol for a national multi-center, double-blinded, placebo-controlled, randomized clinical trial.

Trials·2026
Same author

STHLM3 NorDCaP: prospective multicentre trial of Stockholm3 for active surveillance biopsy guidance.

BJU international·2026

Prostate cancer is the most common male cancer, with increasing incidence. New treatments significantly improve survival and quality of life for patients with metastatic disease.

Area of Science:

  • Oncology
  • Urology
  • Public Health

Background:

  • Prostate cancer is the most frequent male cancer, with ~4,500 annual cases and rising incidence due to demographic shifts.
  • Overdiagnosis presents a significant challenge, as many prostate cancers follow an indolent course without progression.
  • Metastatic prostate cancer is not curable, unlike localized disease, highlighting the need for effective management strategies.

Approach:

  • This review synthesizes current knowledge on prostate cancer epidemiology, diagnosis, and treatment.
  • It examines the complexities of overdiagnosis and its implications for patient outcomes.
  • The review also explores advancements in therapeutic options for advanced prostate cancer.

Key Points:

  • The increasing incidence of prostate cancer necessitates improved diagnostic and management strategies.

Related Experiment Videos

  • Overdiagnosis of indolent disease leads to unnecessary treatment burdens and potential harm.
  • Effective management of metastatic prostate cancer is crucial for improving patient survival and quality of life.

    • Conclusions:

    • Addressing overdiagnosis is critical to optimizing patient care and resource allocation in prostate cancer.
    • Advances in treatment, including combination therapies, offer significant benefits for patients with advanced disease.
    • Continued research into novel therapeutic approaches is essential for further improving outcomes in prostate cancer management.